Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19
- PMID: 32631838
- PMCID: PMC7338404
- DOI: 10.1183/13993003.01808-2020
Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19
Abstract
Patients with COVID-19 should be monitored for rapid onset honeycombing fibrosis
Conflict of interest statement
Conflict of interest: M. Combet has nothing to disclose. Conflict of interest: A. Pavot has nothing to disclose. Conflict of interest: L. Savale reports personal fees and non-financial support from Actelion and MSD, grants, personal fees and non-financial support from GSK, outside the submitted work. Conflict of interest: M. Humbert reports personal fees from Novartis, during the conduct of the study; grants, personal fees and non-financial support from GlaxoSmithKline, personal fees from AstraZeneca, Novartis, Roche, Sanofi and Teva, outside the submitted work. Conflict of interest: X. Monnet has nothing to disclose.
Figures
Comment on
-
Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis.Chin Med J (Engl). 2020 Jun 20;133(12):1390-1396. doi: 10.1097/CM9.0000000000000839. Chin Med J (Engl). 2020. PMID: 32251003 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical